Fort Point Capital Partners LLC Rigel Pharmaceuticals Inc Transaction History
Fort Point Capital Partners LLC
- $749 Million
- Q1 2024
A detailed history of Fort Point Capital Partners LLC transactions in Rigel Pharmaceuticals Inc stock. As of the latest transaction made, Fort Point Capital Partners LLC holds 17,000 shares of RIGL stock, worth $139,740. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,000
Previous 17,000
-0.0%
Holding current value
$139,740
Previous $24,000
4.17%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RIGL
# of Institutions
122Shares Held
110MCall Options Held
556KPut Options Held
33.9K-
Armistice Capital, LLC New York, NY15.4MShares$126 Million0.31% of portfolio
-
Black Rock Inc. New York, NY14.8MShares$122 Million0.0% of portfolio
-
Morgan Stanley New York, NY14.4MShares$119 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.37MShares$77 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT9.24MShares$76 Million1.12% of portfolio
About RIGEL PHARMACEUTICALS INC
- Ticker RIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 172,836,000
- Market Cap $1.42B
- Description
- Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...